Posted inCardiology Internal Medicine news
Bempedoic Acid Significantly Reduces Limb and Cardiovascular Events in Statin-Intolerant Patients with Peripheral Artery Disease: Insights from the CLEAR Outcomes Trial
Bempedoic acid reduces the risk of major adverse limb and cardiovascular events in statin-intolerant patients with peripheral artery disease, illustrating its potential to enhance vascular risk management.
